This report was first published by Endpoints News. To see the original version, click here
Pharma is gaining ground in a yearslong struggle over access to federal drug discounts.
Drugmakers and the federal government have historically been on opposing sides of contract pharmacy policy under 340B. But in a handful of cases against state laws, they’ve become unexpected allies.
您已阅读8%（375字），剩余92%（4261字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。